Any feedback?
Literature summary for 3.4.22.8 extracted from
- Clostripain: characterization of the active site (1991), FEBS Lett., 283, 277-280.
General Stability
| General Stability | Organism |
|---|---|
| Ca2+ stabilizes | Hathewaya histolytica |
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| Aprotinin | - |
Hathewaya histolytica |  |
| benzamidine | weak | Hathewaya histolytica | |
| benzyloxycarbonyl-Phe-Lys-CH2S(CH3)2 | irreversible | Hathewaya histolytica | |
| diethyldicarbonate | - |
Hathewaya histolytica | |
| iodoacetamide | - |
Hathewaya histolytica | |
| iodoacetate | - |
Hathewaya histolytica | |
| L-3-carboxy-2,3-trans-epoxypropionyl-leucylamido-(4-guanidino)butane | i.e. compounds E-64 | Hathewaya histolytica | |
| leupeptin | reversible | Hathewaya histolytica | |
| Trypsin inhibitor | Kunitz soybean trypsin inhibitor; limabean trypsin inhibitor | Hathewaya histolytica |
Metals/Ions
| Metals/Ions | Comment | Organism | Structure |
|---|---|---|---|
| Ca2+ | half-maximal activity at 0.195 mM | Hathewaya histolytica | |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Hathewaya histolytica | - |
- |
- |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
